Inpatient Opioid Treatment Programs

Written by The Recovery Village

& Medically Reviewed by Dr. Kevin Wandler, MD

Medically Reviewed

Last updated: 09/28/2024

This article was reviewed by a medical professional to guarantee the delivery of accurate and up-to- date information. View our research policy.

Editorial Policy

Last Updated - 09/28/2024

View our editorial policy
If you or a loved one is struggling with addiction, help is available. Speak with a Recovery Advocate by calling (856) 890-9449 now.

Key Takeaways

  • Inpatient opioid treatment programs provide a controlled environment for recovery, offering 24/7 medical supervision and structured care.
  • Medication-assisted treatment (MAT), combined with counseling and behavioral therapies, is essential for effective OUD treatment.
  • Inpatient treatment can be more effective than outpatient programs, particularly for individuals with severe addiction or comorbid conditions.
  • Aftercare is crucial in sustaining recovery and preventing relapse after inpatient treatment.
  • Cost, duration, patient readiness, and accessibility are significant challenges in inpatient opioid treatment.
  • Longer durations of treatment correlate with lower rates of overdose and improved quality of life.
  • Comprehensive care in inpatient programs includes detoxification, therapy, medication management, and aftercare planning.
  • Addressing systemic barriers to quality care within opioid treatment programs is essential for maximizing their effectiveness.

Advantages of Inpatient Opioid Treatment Programs

Inpatient opioid treatment programs (OTPs) offer a comprehensive approach to addressing OUD, providing patients with a structured and supportive environment that is conducive to recovery.

  • 24/7 medical supervision: This ensures patients have immediate attention in case of emergencies or complications during the withdrawal process.
  • Distraction-free environment: This keeps patients away from the triggers and temptations of daily life that can hinder recovery. It also allows individuals to focus solely on their rehabilitation and develop coping strategies without external pressures.
  • Structure: The structured nature of inpatient programs also establishes a routine that includes therapy sessions, activities, and peer support, which are crucial for building a foundation for long-term sobriety.

Comprehensive care in inpatient OTPs typically includes a combination of medication-assisted treatment (MAT), evidence-based therapies, and aftercare planning.

MAT medications such as methadone, buprenorphine, and naltrexone are administered to manage withdrawal symptoms and reduce cravings, while various forms of therapy address the psychological aspects of addiction. Aftercare planning is essential for relapse prevention and ensuring continuity of care post-discharge.

Effectiveness of Inpatient Opioid Treatment Programs

Research into inpatient OTPs underscores their critical role in combating OUDs. A study published in JAMA Network Open reveals that longer durations of medication for OUD with buprenorphine or methadone correlate with significantly lower rates of overdose and serious opioid-related acute care use.

Specifically, treatment exceeding 180 days shows a marked decrease in overdose incidents (1.1%) compared to shorter treatment spans or no medication for OUD (3.6%).

Further, the National Center for Biotechnology Information emphasizes that medication for OUD, particularly with methadone or buprenorphine, contributes to reduced opioid use, lower transmission risks for HIV and HCV, and improved social functioning. Extended treatment durations are associated with better quality of life and increased opportunities for employment and rehabilitation.

Key Components of Inpatient Opioid Treatment Programs

Inpatient OTPs are comprehensive interventions designed to address opioid addiction through detoxification, therapy, medication, and aftercare, each playing a vital role in the recovery process.

  • Detoxification: The initial phase of inpatient treatment, detoxification involves medically supervised withdrawal from opioids, managing withdrawal symptoms, and preparing the body for further treatment.
  • Therapy: Various forms of therapy, including cognitive-behavioral therapy, group therapy, and family therapy, are utilized to address the psychological aspects of addiction, improve coping strategies, and facilitate behavior change.
  • Medication: Medication-assisted treatment (MAT) is a critical component of OTPs, using FDA-approved medications like methadone, buprenorphine, and naltrexone to reduce cravings and withdrawal symptoms, which supports sustained recovery.
  • Aftercare: Post-treatment support is essential for maintaining sobriety. Aftercare programs may include ongoing therapy, support groups, and other resources to help prevent relapse and promote long-term recovery.

The Detoxification Process in Inpatient Opioid Treatment

Detoxification is a medically supervised process that is essential for preventing potentially severe physical and psychological withdrawal effects, which can include anxiety, restlessness, gastrointestinal distress, and cravings. The goal is to create a stable physical state for the patient, allowing them to engage in further therapeutic interventions.

Inpatient detoxification provides 24/7 medical supervision, ensuring the safety and comfort of the patient through the use of medications like buprenorphine, methadone, and clonidine. These medications help to reduce the severity of withdrawal symptoms, control cravings, and normalize body functions. For instance, buprenorphine can be as effective as methadone in limiting opioid withdrawal symptoms, and its use is often preferred due to its safety profile and lower potential for misuse.

Despite the effectiveness of inpatient detoxification, it presents challenges including its cost, which can be significantly higher than community-based treatments. Additionally, the detoxification process must be tailored to each individual’s unique circumstances, including their level of dependence and overall health. Post-detoxification support is crucial to prevent relapse, and ongoing treatment typically includes therapy and aftercare planning.

Therapeutic Approaches in Inpatient Opioid Treatment

Inpatient treatment for opioid addiction encompasses a variety of therapeutic approaches designed to address the complex needs of individuals in recovery.

  • Cognitive-behavioral therapy (CBT) is a cornerstone of inpatient treatment, helping patients to recognize and modify negative thought patterns and behaviors related to substance use.
  • Group therapy offers a supportive environment where individuals can share experiences and learn from others facing similar challenges.
  • Family therapy is also integral, as it works to heal relationships affected by addiction and fosters a supportive home environment post-treatment.

Therapies are often complemented by medication-assisted treatment (MAT), which includes FDA-approved medications such as buprenorphine and methadone to manage withdrawal symptoms and reduce cravings. The combination of MAT with therapeutic interventions is considered the gold standard in opioid addiction treatment, as it addresses both the physical and psychological aspects of addiction.

Medication Management in Inpatient Opioid Treatment Programs

Medications such as methadone, buprenorphine, and clonidine are commonly used to ease the withdrawal process and facilitate a smoother transition to long-term treatment for OUD.

  • Methadone, a full opioid agonist, and buprenorphine, a partial agonist, work by binding to the same receptors as other opioids, reducing withdrawal symptoms and cravings without producing the same high.
  • Clonidine helps alleviate withdrawal symptoms by suppressing the ‘fight or flight’ response, thus reducing anxiety, agitation, and other physical symptoms of withdrawal.
  • Transitioning to maintenance medications like naltrexone is another strategy used in inpatient treatment. Naltrexone blocks opioid receptors, preventing the effects of opioids and helping individuals maintain abstinence.

Effective management of opioid withdrawal is crucial as it represents a high-risk period for potential opioid overdose and relapse. As such, inpatient settings provide a controlled environment where medication dosages can be carefully monitored and adjusted, ensuring patient safety and comfort.

Withdrawal management is not only about symptom relief but also about preparing patients for the next steps in their recovery journey, such as engaging in therapy and other treatment modalities.

The Role of Aftercare in Sustaining Recovery from Opioid Addiction

Aftercare is designed to help patients maintain sobriety and prevent relapse after they leave the structured environment of inpatient care. It can include various forms of ongoing support, such as outpatient therapy, support groups, MAT, and lifestyle coaching. The goal of aftercare is to reinforce the coping strategies and healthy habits developed during inpatient treatment, ensuring a smooth transition into everyday life.

Research has shown that care transitions, which include aftercare planning, are essential in linking patients with OUD to continuous treatment and support services. This continuity of care is crucial because it addresses the chronic nature of OUD, helping individuals navigate the challenges of recovery and reducing the likelihood of relapse.

Effective aftercare strategies may involve peer recovery support services (PRSS), which have shown promise in improving access to care, treatment retention, and recovery outcomes. PRSS can be particularly beneficial in addressing barriers to recovery, such as stigma, waitlists, and socioeconomic challenges. These services can provide a personalized approach to aftercare that can significantly enhance the quality of personal and family life in long-term recovery.

Navigating Challenges in Inpatient Opioid Treatment

Cost and Duration of Inpatient Opioid Treatment Programs

The expenses associated with inpatient opioid treatment programs can vary widely depending on several factors, including the type of medication used during the program and the length of the inpatient stay. For instance, a study on the cost of pharmacotherapy following inpatient detoxification revealed that the mean 24-week cost per participant was approximately $5,416, with variations depending on the treatment site and medication type. AJMC reports that costs can range from $2,521 to $8,963.

Moreover, the effectiveness of inpatient treatment is often evaluated against its cost. Research published in JAMA Psychiatry emphasizes the public health crisis of OUD and the cost-effectiveness of various treatments, including MAT. The study suggests that while upfront costs are significant, there are long-term savings to consider, such as reduced criminal justice costs and improved quality of life.

Enhancing Patient Readiness for Inpatient Opioid Treatment

Research indicates that preparedness can significantly influence treatment outcomes. A multifaceted approach is recommended to enhance motivation and readiness for treatment. This includes:

  • Educating patients about harm reduction strategies, such as the use of overdose reversal kits, and ensuring they understand the follow-up plan post-discharge.
  • Addressing barriers to treatment adherence and facilitating access to evidence-based medical treatments like Medications for (OUD).
  • Using the Brief Negotiated Interview (BNI) technique to assess and increase treatment readiness.
  • Maintaining open communication between care managers, addiction medicine specialists, and the patient is vital. Regular follow-up calls post-discharge can help assess the patient’s adherence to the discharge plan and provide ongoing support.
  • Initiating buprenorphine in emergency departments, combined with linkage to outpatient care. This has been shown to reduce mortality and morbidity among persons living with opioid addiction.

However, patients often face barriers to obtaining timely follow-up care post-discharge due to logistical issues such as prescription authorization requirements and coverage gaps.

Seeking Addiction Treatment at The Recovery Village Cherry Hill

If you’re seeking addiction treatment for yourself or a loved one, The Recovery Village Cherry Hill at Cooper is here to help. Our facility is conveniently located within the heart of New Jersey, under 20 minutes from Philadelphia. We have a full range of treatment options, including medical detox, inpatient care, partial hospitalization programming and intensive outpatient services. We offer a state-of-the-art inpatient facility and have specialized options for trauma, including EMDR and a specialty track for veterans and first responders. 

If you or a loved one are ready to begin the journey toward a substance-free life, we’re standing by to take your call. Reach out to our Recovery Advocates to learn more about our treatment programs and find a plan that works well for your specific needs and situation.

Authorship

Get your life back

Recovery is possible. Begin your journey today

Call Us Now Admissions Check Insurance

What To Expect

When you call our team, you will speak to a Recovery Advocate who will answer any questions and perform a pre-assessment to determine your eligibility for treatment. If eligible, we will create a treatment plan tailored to your specific needs. If The Recovery Village is not the right fit for you or your loved one, we will help refer you to a facility that is. All calls are 100% free and confidential.

All calls are 100% free and confidential.